| Dr John R Simmons, MD | |
|
5339 Odonavan, Baton Rouge, LA 70808-4388 | |
| (225) 766-4999 | |
| (225) 767-4702 |
| Full Name | Dr John R Simmons |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 30 Years |
| Location | 5339 Odonavan, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982664397 | NPI | - | NPPES |
| 1148181 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD.14896R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
| Lane Regional Medical Center | Zachary, LA | Hospital |
| Womans Hospital | Baton rouge, LA | Hospital |
| Baton Rouge General Medical Center | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathology Group Of Louisiana, A Professional Medical Corporation | 6507856317 | 22 |
News Archive
Researchers say that there is no significant reduction in angiographic graft failure with arterial grafts compared with saphenous vein grafts in revascularization of the right coronary system.
An international consensus panel led by researchers from The Westmead Institute for Medical Researchhas highlighted the need to redefine Non-Alcoholic Fatty Liver Disease, and to name it Metabolic Associated Fatty Liver Disease. Researchers highlighted that the new terminology will better reflect its causes, and improve public health initiatives.
Biophysicists from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases have teamed up with colleagues from Canada, the U.S., Japan, France, and Germany to shed light on the structure and functioning mechanism of the CysLT receptors, which regulate inflammatory responses associated with allergic disorders.
Infants show unique physiological and behavioral responses to pleasant touch, which may help to cement the bonds between child and parent and promote early social and physiological development, according to research published in Psychological Science, a journal of the Association for Psychological Science.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
› Verified 4 days ago
| Entity Name | Pathology Group Of Louisiana, A Professional Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093843450 PECOS PAC ID: 6507856317 Enrollment ID: O20040514000007 |
News Archive
Researchers say that there is no significant reduction in angiographic graft failure with arterial grafts compared with saphenous vein grafts in revascularization of the right coronary system.
An international consensus panel led by researchers from The Westmead Institute for Medical Researchhas highlighted the need to redefine Non-Alcoholic Fatty Liver Disease, and to name it Metabolic Associated Fatty Liver Disease. Researchers highlighted that the new terminology will better reflect its causes, and improve public health initiatives.
Biophysicists from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases have teamed up with colleagues from Canada, the U.S., Japan, France, and Germany to shed light on the structure and functioning mechanism of the CysLT receptors, which regulate inflammatory responses associated with allergic disorders.
Infants show unique physiological and behavioral responses to pleasant touch, which may help to cement the bonds between child and parent and promote early social and physiological development, according to research published in Psychological Science, a journal of the Association for Psychological Science.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John R Simmons, MD 5339 Odonavan, Baton Rouge, LA 70808-4388 Ph: (225) 766-4999 | Dr John R Simmons, MD 5339 Odonavan, Baton Rouge, LA 70808-4388 Ph: (225) 766-4999 |
News Archive
Researchers say that there is no significant reduction in angiographic graft failure with arterial grafts compared with saphenous vein grafts in revascularization of the right coronary system.
An international consensus panel led by researchers from The Westmead Institute for Medical Researchhas highlighted the need to redefine Non-Alcoholic Fatty Liver Disease, and to name it Metabolic Associated Fatty Liver Disease. Researchers highlighted that the new terminology will better reflect its causes, and improve public health initiatives.
Biophysicists from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases have teamed up with colleagues from Canada, the U.S., Japan, France, and Germany to shed light on the structure and functioning mechanism of the CysLT receptors, which regulate inflammatory responses associated with allergic disorders.
Infants show unique physiological and behavioral responses to pleasant touch, which may help to cement the bonds between child and parent and promote early social and physiological development, according to research published in Psychological Science, a journal of the Association for Psychological Science.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
› Verified 4 days ago
Dr. Brian W. Webb, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 Odonavan, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 | |
Zarius Drummond, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 O'donovan Drive, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 | |
Dr. Leo A. Pei, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 17000 Medical Center Drive, Baton Rouge, LA 70816 Phone: 225-752-2470 | |
Jennifer Jastram-belcher, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 O'donovan Drive, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 | |
Dr. Peggy H. Polk, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5339 Odonavan, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-763-5870 | |
Jonathan C Stone, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 O'donovan Drive, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 | |
Amberly Lindau Nunez, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5339 Odonovan Dr, Baton Rouge, LA 70808 Phone: 225-766-4999 Fax: 225-767-4702 |